X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE MERCK LTD SUVEN LIFE/
MERCK LTD
 
P/E (TTM) x 16.2 26.1 62.2% View Chart
P/BV x 3.0 2.9 103.1% View Chart
Dividend Yield % 1.2 1.0 128.5%  

Financials

 SUVEN LIFE   MERCK LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
MERCK LTD
Dec-16
SUVEN LIFE/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs3391,060 31.9%   
Low Rs144623 23.2%   
Sales per share (Unadj.) Rs39.2632.4 6.2%  
Earnings per share (Unadj.) Rs7.545.7 16.3%  
Cash flow per share (Unadj.) Rs8.862.3 14.1%  
Dividends per share (Unadj.) Rs2.0011.00 18.2%  
Dividend yield (eoy) %0.81.3 63.4%  
Book value per share (Unadj.) Rs49.0388.8 12.6%  
Shares outstanding (eoy) m127.2816.60 766.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.21.3 462.4%   
Avg P/E ratio x32.418.4 175.8%  
P/CF ratio (eoy) x27.513.5 203.8%  
Price / Book Value ratio x4.92.2 227.7%  
Dividend payout %26.824.1 111.4%   
Avg Mkt Cap Rs m30,73213,969 220.0%   
No. of employees `0001.01.6 60.3%   
Total wages/salary Rs m4161,487 28.0%   
Avg. sales/employee Rs Th5,236.16,631.9 79.0%   
Avg. wages/employee Rs Th436.5939.2 46.5%   
Avg. net profit/employee Rs Th995.5479.4 207.7%   
INCOME DATA
Net Sales Rs m4,99510,498 47.6%  
Other income Rs m194242 79.8%   
Total revenues Rs m5,18910,741 48.3%   
Gross profit Rs m1,2331,135 108.6%  
Depreciation Rs m167276 60.7%   
Interest Rs m540-   
Profit before tax Rs m1,2051,102 109.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255343 74.3%   
Profit after tax Rs m950759 125.1%  
Gross profit margin %24.710.8 228.2%  
Effective tax rate %21.231.1 68.0%   
Net profit margin %19.07.2 263.0%  
BALANCE SHEET DATA
Current assets Rs m4,9866,410 77.8%   
Current liabilities Rs m1,0428,828 11.8%   
Net working cap to sales %79.0-23.0 -342.7%  
Current ratio x4.80.7 658.9%  
Inventory Days Days6158 105.7%  
Debtors Days Days3938 102.0%  
Net fixed assets Rs m3,1261,406 222.2%   
Share capital Rs m127166 76.7%   
"Free" reserves Rs m3,7176,286 59.1%   
Net worth Rs m6,2366,455 96.6%   
Long term debt Rs m4320-   
Total assets Rs m8,0798,828 91.5%  
Interest coverage x23.2NM-  
Debt to equity ratio x0.10-  
Sales to assets ratio x0.61.2 52.0%   
Return on assets %12.48.6 144.5%  
Return on equity %15.211.8 129.5%  
Return on capital %18.917.1 110.6%  
Exports to sales %87.58.3 1,056.5%   
Imports to sales %12.221.0 58.1%   
Exports (fob) Rs m4,371869 502.7%   
Imports (cif) Rs m6112,209 27.6%   
Fx inflow Rs m4,666959 486.7%   
Fx outflow Rs m9422,612 36.1%   
Net fx Rs m3,724-1,653 -225.3%   
CASH FLOW
From Operations Rs m9221,070 86.1%  
From Investments Rs m-619-750 82.6%  
From Financial Activity Rs m-698-150 466.2%  
Net Cashflow Rs m-396171 -231.5%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 0.0 1.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 29.1 125.4%  
Shareholders   37,287 28,591 130.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   GSK PHARMA  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 18, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS